Product analysis
PMS combines ingredients with possible links to stress-associated mood support. Undisclosed blend contents make it difficult to judge the contribution of ashwagandha.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality39
Evening primrose and 5-HTP sources are identified, but their relative quality remains uncertain. The unidentified blend contents prevent a complete comparison.
Ingredient Transparency70
The listed amounts and most forms are disclosed. The blend contents are unspecified, so its total weight cannot establish an individual ashwagandha amount.
Value For Money8
The cost compares poorly for the amount of 5-HTP. Value for evening primrose remains uncertain.
Customer Satisfaction67
Customer ratings are generally very positive. A smaller collection of ratings gives a narrower view of customer satisfaction.
Product Focus40
The formula has possible links to mood and stress support, with uncertain everyday benefits. The undisclosed ashwagandha amount prevents a useful expectation of its contribution.
- Format
Capsule - Container
- 30 Capsule(s)
- Per serving
- $0.47
- Customer rating
- 4.5 · 44 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Evening Primrose, Powder (Oenothera biennis, Powder) | 250 mg | |
Proprietary Blend | 300 mg | |
5-HTP (Griffonia simplicifolia Extract) | 50 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability70
Botanical Source & Standardization
Dose, Safety & Label Transparency49
Dosage Potency & Range
Safety Warnings & Label Clarity
Value0
Price per 100mg 5-HTP
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Comparative study of efficacy of l-5-hydroxytryptophan and fluoxetine in patients presenting with first depressive episode.
- The Impact of 5-Hydroxytryptophan Supplementation on Cognitive Function and Mood in Singapore Older Adults: A Randomized Controlled Trial.
- Effects of 5-hydroxytryptophan on distinct types of depression: a systematic review and meta-analysis.
- Tryptophan and 5-hydroxytryptophan for depression.
- 5-Hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depressions. A double-blind controlled study.
- A proprietary herbal extract of ashwagandha root for stress and anxiety in healthy adults: a randomized, double-blind, three-arm, placebo-controlled efficacy and safety study.
- Safety and efficacy of Withania somnifera for anxiety and insomnia: Systematic review and meta-analysis.
- A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults.
- Effects of multi-herb and ashwagandha root formulas on stress modulation: a randomized, double-blind, placebo-controlled clinical study.
- Medicinal herbs for the treatment of anxiety: A systematic review and network meta-analysis.
- Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo.
- Acute L-5-hydroxytryptophan administration inhibits carbon dioxide-induced panic in panic disorder patients.
- Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa.
- Enhanced tolerability of the 5-hydroxytryptophane challenge test combined with granisetron.
- An open-label trial of L-5-hydroxytryptophan in subjects with romantic stress.
- An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study.
- Shoden promotes Relief from stress and anxiety: A randomized, double-blind, placebo-controlled study on healthy subjects with high stress levels.
- Efficacy and Safety of Ashwagandha Root Extract on Cognitive Functions in Healthy, Stressed Adults: A Randomized, Double-Blind, Placebo-Controlled Study.
- Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study.